Alpha adrenergic receptor modulators

Details for Australian Patent Application No. 2010310800 (hide)

Owner Allergan, Inc.

Inventors Chow, Ken; Wang, Liming; Fang, Wenkui K.; Corpuz, Evelyn G.; Gil, Daniel W.

Agent Davies Collison Cave

Pub. Number AU-A-2010310800

PCT Pub. Number WO2011/050030

Priority 61/253,654 21.10.09 US

Filing date 20 October 2010

Wipo publication date 28 April 2011

International Classifications

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/050030 Priority application(s): WO2011/050030

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310801-Spinal implant with a flexible extension element

2010310788-Compositions and methods for controlling pupil dilation comprising phentolamine